Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for testing related substances of levocetirizine hydrochloride intermediate

A technology of levocetirizine hydrochloride and a determination method, applied in the field of analytical chemistry, can solve the problems of incomplete removal of impurities, influence on the purity and quality of drugs, etc., and achieve the effect of ensuring quality and controllable quality

Inactive Publication Date: 2015-04-29
AVENTIS PHARMA HAINAN
View PDF3 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Impurities in the intermediate of levocetirizine hydrochloride are not completely removed, and will be introduced into the final product of the raw material drug, thereby affecting the purity and quality of the drug

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for testing related substances of levocetirizine hydrochloride intermediate
  • Method for testing related substances of levocetirizine hydrochloride intermediate
  • Method for testing related substances of levocetirizine hydrochloride intermediate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] Instruments and Conditions

[0037] High performance liquid chromatography: Shimadzu: LC-20AT, CBM-20A, SIL-20AC, SPD-M20A, CTO-10ASvp;

[0038] Column: C 18 (Kromasil, 250×4.6 mm, 5 μm);

[0039] Mobile phase: 0.02 mol / L potassium dihydrogen phosphate buffer solution (pH 3.0)-acetonitrile (60:40);

[0040] Flow rate: 1.0 mL / min

[0041] Detection wavelength: 230 nm

[0042] Column temperature: 25°C

[0043] Injection volume: 10 μL.

[0044] Experimental procedure

[0045] Take an appropriate amount of levocetirizine hydrochloride intermediate and its related substances, dissolve the samples in acetonitrile respectively, and prepare a sample solution containing about 0.5 mg / mL of levocetirizine hydrochloride intermediate and its related substances. Perform HPLC analysis according to the above conditions, and record the chromatograms. see attached results Figure 1~2 , figure 1 The chromatographic peak whose retention time is 12.529 min is the levocetirizine h...

Embodiment 2

[0047] Instruments and Conditions

[0048] High performance liquid chromatography: Shimadzu: LC-20AT, CBM-20A, SIL-20AC, SPD-M20A, CTO-10ASvp;

[0049] Column: C 18 (Kromasil, 250×4.6 mm, 5 μm);

[0050] Mobile phase: 0.02 mol / L sodium dihydrogen phosphate buffer solution (pH 3.0)-acetonitrile (65:35);

[0051] Flow rate: 1.0 mL / min

[0052] Detection wavelength: 230 nm

[0053] Column temperature: 25°C

[0054] Injection volume: 10 μL.

[0055] Experimental procedure

[0056] Take an appropriate amount of levocetirizine hydrochloride intermediate and its related substances, dissolve the samples in acetonitrile respectively, and prepare a sample solution containing about 0.5 mg / mL of levocetirizine hydrochloride intermediate and its related substances. Perform HPLC analysis according to the above conditions, and record the chromatograms. see attached results Figure 3~4 , image 3 The chromatographic peak whose retention time is 22.297 min is the levocetirizine hydro...

Embodiment 3

[0058] Instruments and Conditions

[0059] High performance liquid chromatography: Shimadzu: LC-20AT, CBM-20A, SIL-20AC, SPD-M20A, CTO-10ASvp;

[0060] Column: C 18 (Kromasil, 250×4.6 mm, 5 μm);

[0061] Mobile phase: 0.02 mol / L dipotassium hydrogen phosphate buffer solution (pH 6.0)-acetonitrile (65:35);

[0062] Flow rate: 1.0 mL / min

[0063] Detection wavelength: 230 nm

[0064] Column temperature: 25°C

[0065] Injection volume: 10 μL.

[0066] Experimental procedure

[0067] Take an appropriate amount of levocetirizine hydrochloride intermediate and its related substances, dissolve the samples with acetonitrile respectively, and prepare a sample solution containing about 0.5 mg / mL of levocetirizine hydrochloride intermediate and its related substances; another appropriate amount of acetonitrile is used as blank solvent. Perform HPLC analysis according to the above conditions, and record the chromatograms. see attached results Figure 5~7 , Figure 5 is the solven...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of analytical chemistry, and discloses a method for separately testing a levocetirizine hydrochloride intermediate and related substances of the levocetirizine hydrochloride intermediate by liquid chromatography. The method comprises the following steps: a chromatographic column taking octadecylsilane chemically bonded silica as a filler uses a certain proportion of buffer salt solution-organic phase as a mobile phase to quantificationally test the content of the levocetirizine hydrochloride intermediate and the content of the related substances of levocetirizine hydrochloride intermediate, so that the quality of the levocetirizine hydrochloride intermediate is effectively controlled, and the controllable quality of levocetirizine hydrochloride is ensured. The method is high in specificity and accuracy, and simple and convenient to operate.

Description

technical field [0001] The invention belongs to the field of analytical chemistry, in particular to a method for separating and measuring levocetirizine hydrochloride intermediates and related substances by liquid chromatography. Background technique [0002] Levocetirizine hydrochloride is used to relieve allergic symptoms of allergic diseases, clinically used to treat allergic rhinitis, urticaria, angioedema and other skin and mucous membrane allergic diseases, and also used to reduce allergic symptoms of colds . The chemical name of the intermediate of levocetirizine hydrochloride is 2-(4-((4-chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethanol, and the molecular formula is C 19 h 23 ClN 2 O. The structural formula of levocetirizine hydrochloride intermediate is: [0003] . [0004] In the process of synthesizing this compound, some important intermediates may affect the purity and quality of the drug due to incomplete removal. For the synthesis of levocetirizine hy...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N30/88
Inventor 杨敏王宇杰马苏峰
Owner AVENTIS PHARMA HAINAN
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com